Advertisement

Topics

Companies Related to "Odonate Therapeutics, Inc." [Most Relevant Company Matches] - Page: 5 [Advanced Search Results] RSS

04:05 EDT 18th June 2018 | BioPortfolio

Here are the most relevant search results for "Odonate Therapeutics, Inc." found in our extensive corporate database of over 50,000 company records.

Showing "Odonate Therapeutics" Companies 101–125 of 1,600+

Probably Relevant

Advanced Cancer Therapeutics (ACT)

ACT is a for-profit private company dedicated to advancing novel therapeutics for the prevention and treatment of cancer. ACT has successfully established a unique and innovative business model with the University of Louisville’s James Graham Brown Cancer Center (Brown Cancer Center) whereby ACT is able to obtain exclusive worldwide licenses to novel ...


Aileron Therapeutics

Aileron Therapeutics is a biopharmaceutical company leading the development of a new therapeutic modality and class of drugs called Stapled Peptides. Published research on Stapled Peptides has demonstrated their unique ability to modulate intracellular protein-protein interactions, critical control points for most human diseases that have been largely undr...

Therabron Therapeutics, Inc.

Therabron Therapeutics, Inc. is a clinical-stage biotechnology company, founded in 2007 and located in Rockville, MD. Therabron is focused on the advancement of respiratory therapeutics with disease-modifying potential. The company’s product candidates aim to restore the natural immune balance in the lungs of respiratory patients through the administr...


Lodo Therapeutics Corporation

Lodo Therapeutics Corporation is a drug discovery and development company focused on the creation of novel therapeutics derived from nature that will impact patients around the world. The company was established to pursue the scientific vision of Dr. Sean Brady, head of The Rockefeller University's Laboratory of Genetically Encoded Small Molecules. Lodo ...

Bicycle Therapeutics Ltd.

Bicycle Therapeutics is a biotechnology company developing a platform technology that enables the creation of a new generation of biotherapeutics which combine the desirable features of small molecules and biopharmaceuticals to create highly specific and highly stable drugs. Applying phage selection techniques to repertoires of chemically constrained cyclic peptides allows the identification and ...

Orion Therapeutics, LLC

Orion Therapeutics is a Troy, Michigan-based biotech company with a mission to discover, develop and commercialize novel products derived from neutraceutical and food supplement materials to improve human health. Visit www.oriontherapeutics.com.

Sevion Therapeutics, Inc.

Sevion Therapeutics is a biopharmaceutical company building and developing a portfolio of innovative therapeutics, from both internal discovery and acquisition, for the treatment of cancer and immunological diseases. The Company’s product candidates are derived from multiple key proprietary technology platforms: cell-based arrayed antibody discovery, ...

Sevion Therapeutics Inc.

Sevion Therapeutics, Inc. is a biopharmaceutical company building and developing a portfolio of innovative therapeutics, from both internal discovery and acquisition, for the treatment of cancer and immunological diseases. The Company’s product candidates are derived from multiple key proprietary technology platforms: cell-based arrayed antibody discovery, ...

Aryx Therapeutics

Aryx Therapeutics is a privately is a privately-held,produc-driven pharmaceutical company with leading expertise and significant intellectual property in the area of retrometabolic drug design

Hibernation Therapeutics USA, LLC

For more information on Hibernation Therapeutics, its Adenocaine® technologies and intellectual property, please visit www.Adenocaine.com.

Sarepta Therapeutics

Innovative RNA-Based Technology; First-in-Class Therapeutics Sarepta Therapeutics – formerly AVI BioPharma – remains focused on developing first-in-class, RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. Sarepta’s unique technology has yielded a diverse pipeline of RNA-based therapeutics that...

Origen Therapeutics, Inc.

Origen Therapeutics is a biotechnology company developing product opportunities arising from the emerging field of avian transgenic animal technology. The company's mission is to become the leading developer of a novel class human immunotherapeutics known as fully human sequence polyclonal antibodies. These antibodies are expected to have significant advantages over monoclonal antibodies that curr...

Kalytera Therapeutics, Inc.

Kalytera Therapeutics, Inc. ("Kalytera") is pioneering the development of a next generation of cannabinoid therapeutics. Through its proven leadership, drug development expertise, and intellectual property portfolio, Kalytera seeks to establish a leading position in the development of novel cannabinoid medicines for a range of important unmet medical needs...

Trillium Therapeutics Inc

Trillium Therapeutics Inc. (TTI), a research-driven biopharmaceutical company with a strong immunology focus, specializes in the discovery and development of innovative therapies for the treatment of immune-mediated disorders. The company’s therapeutic approaches are aimed at restoring balance to the immune system in conditions associated with aberrant and harmful immune responses, such as autoi...

Wellstat Therapeutics Corporation

Wellstat Therapeutics™ Corporation is a privately-held biopharmaceutical company located in Gaithersburg, Maryland. Dedicated to the discovery, development and commercialization of innovative therapeutics that expand the frontier of modern medicine, Wellstat Therapeutics Corporation is committed to improving the lives of patients with chronic and life-threatening diseases.

Lung Therapeutics, Inc.

Lung Therapeutics, Inc. is a pharmaceutical company formed to leverage 25 years of leading research in lung injury and disease by pursuing niche, orphan drug indications for which there is no current effective therapeutic option. Current pipeline programs include LTI-01 Pleural Effusion (PE) with Loculation, LTI-02 Acute Lung Injury (ALI) and LTI-03 Idiopa...

InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp. is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of proprietary technology co-invented by Robert Langer, ScD, Professo...

Affibody

Affibody has developed a unique pipeline of affinity ligands in oncology, covering the entire value chain from research reagents to molecular imaging agents and targeted therapeutics. The company has obtained outstanding clinical molecular imaging results and promising targeted therapeutics pre-clinical results. Affibody expects to launch one molecular imaging agent per year from 2007 and to file ...

Hyperion Therapeutics, Inc.

Hyperion Therapeutics is a privately held pharmaceutical company focused on the development of therapies that address critical unmet needs and underserved patient populations in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of Medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-...

Tango Therapeutics

Tango Therapeutics is a biotechnology company developing novel medicines for patients by discovering and drugging context-dependent vulnerabilities in cancers. Tango was launched in 2017 by Third Rock Ventures and is headquartered in Cambridge, Mass. For more information, please visit www.tangotx.com.

Triad Therapeutics Incorporated

The genomic revolution is rapidly producing an abundance of new drug targets, but the development of therapeutics requires a leap from the sequences of proteins to the small molecules which modulate them. Scientists at Triad Therapeutics have developed a proprietary technology named Integrated Object-Oriented PharmacoEngineering (IOPE®) to leverage genomic information and dramatically shorten the...

Velcura Therapeutics, Inc.

Velcura Therapeutics, Inc. is an early stage biotechnology company headquartered in Ann Arbor, Michigan. Velcura's research focus is to understand human bone disease and to discover novel therapeutics that restore bone health. Velcura develops highly differentiated therapies for bone disease; specifically, therapies that restore the balance between bone building and bone loss activities in a s...

Pathway Therapeutics, Inc.

Pathway Therapeutics is a privately held pharmaceutical company focused on the discovery and development of best in class, selective inhibitors of PI3K/mTOR for the treatment of cancer and inflammatory diseases in targeted patient populations most likely to benefit. The company was founded in 2008 based on technology from the University of Auckland. The co...

Respira Therapeutics

Respira Therapeutics is an early-stage product development company focused on pulmonary delivery of therapeutics for respiratory diseases with unmet medical needs. The company realized seed capitalization from the Cottonwood Technology Fund on October 2010 for scientific development and commercialization of its seminal intellectual property on DPI. ...

Sevion Therapeutics

Sevion Therapeutics is a clinical-stage company building and developing a portfolio of innovative therapeutics, from both internal discovery and acquisition, for the treatment of cancer and immunological diseases. The Company’s product candidates are derived from multiple key proprietary technology platforms: cell-based arrayed antibody discovery, ultralong ...


More From BioPortfolio on "Odonate Therapeutics, Inc."

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks